SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Arena Pharmaceuticals Q1 EPS $(2.000) Beats $(2.280) Estimate, Sales $262.000K Miss $1.580M Estimate

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(2.000) per share which beat the analyst consensus estimate of $(2.280) by 12.28 percent. This is a 116.21 percent decrease over earnings of $12.340 per

Benzinga · 05/07/2020 20:28

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(2.000) per share which beat the analyst consensus estimate of $(2.280) by 12.28 percent. This is a 116.21 percent decrease over earnings of $12.340 per share from the same period last year. The company reported quarterly sales of $262.000 thousand which missed the analyst consensus estimate of $1.580 million by 83.42 percent. This is a 99.97 percent decrease over sales of $801.057 million the same period last year.